Selection ofMycoplasma genitaliumstrains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin: Table 1

Authors:

Abstract
Objective: A single 1 g dose regimen of azithromycin has been recommended for the treatment ofMycoplasma genitaliuminfections. The authors evaluated whether this regimen could selectM genitaliumstrains with macrolide resistance after treatment forM genitalium-positive non-gonococcal urethritis.Methods: In seven men with non-gonococcal urethritis, who were infected withM genitaliumwithout macrolide resistance-associated mutations but experienced microbiological azithromycin treatment failure,M genitaliumDNAs in their post-treatment urine specimens were examined for mutations in the 23S rRNA gene and the ribosomal protein genes of L4 and L22. To assess the relatedness ofM genitaliumstrains before and after treatment, their DNAs in pretreatment and post-treatment urine were genotyped by analysing short tandem repeats of an AGT/AAT unit in the MG309 gene and single nucleotide polymorphisms in the MG191 gene.Results: In four of seven patients,M genitaliumin post-treatment urine had an A-to-G transition at nucleotide position 2071 or 2072, corresponding to 2058 or 2059 in the 23S rRNA gene ofEscherichia coli. In one of the four strains, Pro81Ser in the ribosomal protein L4 accompanied the mutation in the 23S rRNA gene. The genotyping ofM genitaliumDNAs suggested that these four post-treatment strains were selected from the respective closely related or identical pretreatment strains without macrolide resistance-associated mutations by the treatment.Conclusions: The single 1 g dose treatment of azithromycin could selectM genitaliumstrains harbouring macrolide resistance-associated mutations. ForM genitalium, this regimen might increase the risk of macrolide resistance selection after treatment.

This publication has 10 references indexed in Scilit: